Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC—Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy

INTRODUCTION: In Japan, adjuvant tegafur-uracil (UFT) chemotherapy is recommended for patients with completely resected, stage I NSCLC. This treatment requires real-world re-evaluation because of recent advances in target-based and immuno-oncological treatments and refinement of lung cancer staging....

Descripción completa

Detalles Bibliográficos
Autores principales: Shukuya, Takehito, Takamochi, Kazuya, Sakurai, Hiroyuki, Yoh, Kiyotaka, Hishida, Tomoyuki, Tsuboi, Masahiro, Goto, Yasushi, Kudo, Yujin, Ohde, Yasuhisa, Okumura, Sakae, Taguri, Masataka, Kunitoh, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117917/
https://www.ncbi.nlm.nih.gov/pubmed/35601927
http://dx.doi.org/10.1016/j.jtocrr.2022.100320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117917/
https://www.ncbi.nlm.nih.gov/pubmed/35601927
http://dx.doi.org/10.1016/j.jtocrr.2022.100320

Ejemplares similares